PetVivo to acquire PiezoBioMembrane for 3M shares; builds biomaterials platform

PetVivo Holdings, Inc.

PetVivo will issue 3M restricted common shares to PBM shareholders; portion subject to milestone-based forfeiture.
Milestones include product development Statement of Work, regulatory planning, and clinical authorization.
Closing requires PetVivo to complete equity financing with at least $5.0M in gross proceeds.
PBM's platform includes proprietary biomaterials for tissue repair; will operate under Cosmeta Corp.
Key PBM personnel to continue via consulting; deal expected to accelerate product development across animal and human health.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.